A clinical update on female androgen insufficiency - Testosterone testing and treatment in women presenting with low sexual desire

Sexual Health

Volumn 3, Issue 2, 2006, Pages 73-78

  Burger, Henry G ^a   Papalia, Mary Anne ^b  

^a Jean Hailes Foundation for Women's Health   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CONTRACEPTIVE AGENT; ESTROGEN; FLUOXYMESTERONE; GLUCOCORTICOID; HIGH DENSITY LIPOPROTEIN; METHYLTESTOSTERONE; SEX HORMONE BINDING GLOBULIN; STANOZOLOL; TESTOSTERONE; TESTOSTERONE DERIVATIVE; TIBOLONE;

ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; ACNE; ADRENAL INSUFFICIENCY; ANDROGEN BLOOD LEVEL; ANDROGEN DEFICIENCY; BREAST CANCER; CALCULATION; CANCER; CARDIOVASCULAR DISEASE; CHOLESTATIC HEPATITIS; DATA ANALYSIS; DRUG FATALITY; ENDOMETRIUM HYPERPLASIA; HIRSUTISM; HORMONE DETERMINATION; HUMAN; HYPERANDROGENISM; HYPOPITUITARISM; JAUNDICE; LIBIDO; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; LIVER FAILURE; MEASUREMENT; MENOPAUSAL SYNDROME; METHODOLOGY; ORAL CONTRACEPTION; OVARY INSUFFICIENCY; QUANTITATIVE ANALYSIS; RELIABILITY; REVIEW; SAFETY; SENSITIVITY ANALYSIS; TESTOSTERONE BLOOD LEVEL;

ANDROGENS; AROUSAL; FEMALE; HUMANS; LIBIDO; MENOPAUSE; MIDDLE AGED; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TESTOSTERONE; WOMEN'S HEALTH;

EID: 33744808280     PISSN: 14485028     EISSN: None     Source Type: Journal    
DOI: 10.1071/SH05055     Document Type: Review

References (34)

1. Rivera-Woll LM, Papalia M, Davis SR, Burger HG. Androgen insufficiency in women: diagnostic and therapeutic implications. Hum Reprod Update 2004; 10: 421-32. doi: 10.1093/humupd/dmh037
2. Basson R. Women's sexual dysfunction: revised and expanded definitions. CMAJ 2005; 172: 1327-33.
3. Bachmann GA, Bancroft J, Braunstein G, Burger H, Davis SR, Dennerstein L, et al. Female androgen insufficiency: The Princeton Consensus Statement on definition, classification and assessment. Fertil Steril 2002; 77: 660-5.
4. Miller KK, Sesmilo G, Schiller A, Schonfeld D, Burton S, Klibanski A. Androgen deficiency in women with hypopituitarism. J Clin Endocrinol Metab 2001; 86: 561-7. doi: 10.1210/jc.86.2.561
5. Davison S, Bell R, Donath S, Montalto J, Davis S. Androgen levels in adult females: changes with age, menopause and oophorectomy. J Clin Endocrinol Metab 2005; 90: 3847-53. doi: 10.1210/JC.2005-0212
6. Burger HG, Dudley EC, Cui J, Dennerstein L, Hooper J. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab 2000; 85: 2832-8. doi: 10.1210/jc.85.8.2832
7. Dennerstein L, Lehert P, Burger H. The Relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition. Fertil Steril 2005; 84: 174-80. doi: 10.1016/j.fertnstert.2005.01. 119
8. Dennerstein L, Smith AMA, Morse CA, Burger H. Sexuality and the menopause. J Psychsom Obstet Gynecol 1994; 15: 56-9.
9. McCoy NL, Davidson JM. A longitudinal study of the effects of menopause on sexuality. Maturitas 1985; 7: 203-10. doi: 10.1016/0378-5122(85)90041-6
10. Appelt H, Strauss B. The psychoendocrinology of female sexuality. A research project. German Journal of Psychology 1986; 10: 143-56.
11. Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels and self-reported sexual function in women. JAMA 2005; 294: 91-6. doi: 10.1001/jama.294.1.91
12. Sodergard R, Backstrom T, Shanhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 1982; 16: 801-10. doi: 10.1016/0022-4731(82)90038-3
13. Barrett-Connor E, Von Muhlen DG, Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo study. J Clin Endocrinol Metab 1999; 84: 573-7. doi: 10.1210/jc.84.2.573
14. Wang M, Seippel L, Purdy RH, Backstrom T. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. J Clin Endocrinol Metab 1996; 81: 1076-82. doi: 10.1210/jc.81.3.1076
15. Dimitrakakis C, Zhou J, Wang J, Belanger A, LaBrie F, Cheng C, et al. A physiological role for T in limiting oestrogenic stimulation of the breast. Menopause 2003; 10: 292-8. doi: 10.1097/01.GME.0000055522.67459.89
16. Dimitrakakis C, Jones RA, Liu A, Bondy CA. Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy. Menopause 2004; 11: 531-5. doi: 10.1097/01.GME.0000119983.48235.D3
17. Somboonporn W, Davis S. Testosterone effects on the breast: implications for testosterone therapy for women. Endocr Rev 2004; 25: 374-88. doi: 10.1210/er.2003-0016
18. Arlt W, Callies F, Van Vlijmen JC, Koehler I. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999; 341: 1013-20. doi: 10.1056/NEJM199909303411401
19. Flynn MA, Weaver-Osterholtz D, Sharpe-Timms KL, Allen S, Krause G. Dehydroepiandrosterone replacement in aging humans. J Clin Endocrinol Metab 1999; 84: 1527-33. doi: 10.1210/jc.84.5.1527
20. Burger HG, Hailes J, Menelaus M. The management of persistent symptoms with estradiol-testosterone implants: clinical, lipid and hormonal results. Maturitas 1984; 6: 351-8. doi: 10.1016/0378-5122(84)90008-2
21. Sherwin BB, Gelfand MM. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med 1987; 49: 397-409.
22. Shifren JL, Braunstein G, Simon J, Casson P, Buster JE, Red Burki RE, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000; 343: 682-8. doi: 10.1056/NEJM20000 9073431002
23. Buster JE, Kingsberg SA, Aguirre O, Brown C, Breaux JG, Buch A, et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol 2005; 105: 944-52.
24. Davis SR, McCloud PI, Strauss BJG, Burger HG. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 1995; 21: 227-36. doi: 10.1016/0378-5122(94)00898-H
25. Sarrel P, Dobay B, Wiita B. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses. J Reprod Med 1998; 43: 847-56.
26. Kenemans P. Speroff L. Tibolone: Clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group. Maturitas 2005; 51: 21-8. doi: 10.1016/j.maturitas.2005.02.011
27. Phillips E, Bauman C. Safety surveillance of esterified estrogens-methyltestosterone (Estratest and Estratest HS) replacement therapy in the United States. Clin Ther 1997; 19: 1070-84. doi: 10.1016/S0149-2918(97) 80060-4
28. Bilezikian JP, Morishima A, Bell J, Grumbach MM. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 1998; 339: 599-603. doi: 10.1056/NEJM199808273390905
29. Buchanan JR, Hospodar P, Myers C, Leuenberger P, Demers LM. Effect of excess endogenous androgens on bone density in young women. J Clin Endocrinol Metab 1988; 67: 937-43.
30. Gregoriou O, Kouskouni E, Bakas P, Konidaris S, Papadias K, Kalovidouris A, et al. Bone mineral density in women with idiopathic hirsutism 1. Gynecol Endocrinol 2000; 14: 364-8.
31. Montgomery J, Brincat M, Appleby L, Versi E, Fenwick P, Studd JWW. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1987; 329: 297-9. doi: 10.1016/S0140-6736(87)92026-5
32. Dixon JE, Rodin A, Murby B, Chapman MG, Fogelman I. Bone mass in hirsute women with androgen excess 1. Clin Endocrinol (Oxf) 1989; 30: 271-7.
33. Velthuis-te EJM, Wierik PT, Hendricks T, Boerstoel-Streefland M. Clinical background for women prescribed tibolone or combined estrogen+progesterone therapies: a UK MediPlus study. Climacteric 2004; 7: 187-209.
34. Davidson BJ, Ross RK, Paganini-Hill A, Hammond GD, Siiteri PK, Judd HL. Total and free estrogens and androgens in postmenopausal women with hip fractures. J Clin Endocrinol Metab 1982; 54: 115-20.